|
Albuminuria
|
3
|
Resverlogix Corp.
|
Dec 02, 2019 03:36PM
|
|
Big Pharm
|
2
|
Resverlogix Corp.
|
Oct 02, 2024 01:23PM
|
|
CHF
|
8
|
Resverlogix Corp.
|
Nov 18, 2019 09:21AM
|
|
Newbi On Board
|
4
|
Resverlogix Corp.
|
Jul 29, 2016 04:14AM
|
|
Re: A comment about market penetration
|
3
|
Resverlogix Corp.
|
Mar 18, 2017 05:12PM
|
|
Re: A comment about market penetration
|
6
|
Resverlogix Corp.
|
Mar 21, 2017 10:08AM
|
|
Re: A comment about market penetration
|
9
|
Resverlogix Corp.
|
Mar 19, 2017 06:02PM
|
|
Re: A few thoughts
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 03:38PM
|
|
Re: All things considered.....
|
6
|
Resverlogix Corp.
|
May 25, 2019 07:19AM
|
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
3
|
Resverlogix Corp.
|
Aug 08, 2019 03:55PM
|
|
Re: Bear
|
4
|
Resverlogix Corp.
|
Jan 18, 2020 04:03PM
|
|
Re: BETonMACE and Aminotransferases
|
5
|
Resverlogix Corp.
|
Aug 14, 2019 04:50PM
|
|
Re: BETonMACE and Aminotransferases
|
5
|
Resverlogix Corp.
|
Aug 14, 2019 07:29PM
|
|
Re: BETonMACE Placebo Estimate
|
4
|
Resverlogix Corp.
|
Feb 20, 2019 04:32PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
5
|
Resverlogix Corp.
|
Mar 23, 2019 03:39PM
|
|
Re: Brilanta-AZ
|
7
|
Resverlogix Corp.
|
Apr 19, 2018 08:49PM
|
|
Re: Brilinta-AZ
|
4
|
Resverlogix Corp.
|
Apr 19, 2018 11:53PM
|
|
Re: Can anyone say....
|
5
|
Resverlogix Corp.
|
Sep 25, 2019 12:12AM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
6
|
Resverlogix Corp.
|
Feb 08, 2022 09:35PM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
18
|
Resverlogix Corp.
|
Feb 02, 2022 12:42AM
|
